Delivery Order SPE2DB20D3505-SPE2DB24FV0M2

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ALPHAGAN P 0.15% eye drops in 10ml bottles. The contract has a ceiling value of $7,471.82 and a completion date of September 3, 2024. It is a firm fixed-price contract, and there is no set-aside designation. Amerisourcebergen is the prime contractor, and the contract is part of a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,207.92, is for the delivery of ALPHAGAN P 0.1% DROPS 10ML, a pharmaceutical product. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and there is no mention of any major subcontractors. The DLA, a defense...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Alphagan P 0.1% ophthalmic drops. The contract has a ceiling value of $2,349.64 and is a firm fixed-price delivery order with an ultimate completion date of August 23, 2024. There is no set-aside designation for this award. Amerisourcebergen, through its extensive federal contract portfolio, provides a wide range of critical pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,852.29 Firm Fixed Price delivery order is for the supply of ALPHAGAN P 0.1% DROPS 15ML, a pharmaceutical product. The contract has an ultimate completion date of December 19, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,451.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of ALPHAGAN P 0.1% DROPS 5ML, a pharmaceutical product, with a completion date of February 4, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,789.13, is for the delivery of Alphagan P 0.1% eye drops, with a completion date of July 5, 2024. This contract is a firm fixed-price delivery order, and it is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Alphagan P 0.1% eye drops, a prescription medication used to treat glaucoma. The contract has a firm fixed price of $5,040.91 and a completion date of November 25, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,154.52, is for the supply of ALPHAGAN P 0.15% eye drops in 5 ml containers. The contract has an ultimate completion date of July 5, 2023 and does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $11,570.46 firm fixed-price contract is for the supply of ALPHAGAN P 0.15% eye drops in 5 ml bottles. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999, for providing a wide range of pharmaceutical products and medical supplies...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the supply of ALPHAGAN P 0.15% eye drops, a prescription medication, to support federal healthcare programs. The contract has a ceiling value of $5,609.70 and an ultimate completion date of August 29, 2024. There is no set-aside designation for this contract. AmerisourceBergen holds several Indefinite...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB24FV0M2
    Delivery Order

This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,353.72, is for the delivery of ALPHAGAN P 0.1% DROPS 5ML, a pharmaceutical product. The contract has a firm fixed price and a completion date of September 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:14 AM